2
Jun 2026
A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS/RAS, EGFR/HER2, and STAT3 signaling. The approach prevented treatment resistance across mouse and human tumor-derived models, but remains preclinical and requires more clinically suitable drug combinations before human testing.
2
Jun 2026
This Burden of Proof review found that alcohol consumption is associated with higher risks for several cancers, liver disease, pancreatitis, lower respiratory infections, tuberculosis, and atrial fibrillation. Although low-to-moderate drinking showed modest observational links with lower risks of type 2 diabetes, dementia, and some cardiovascular outcomes, the evidence was weaker and potentially biased.
2
Jun 2026
Researchers developed Passive Heart-Rate Monitoring, a deep-learning smartphone system that estimates heart rate and daily resting heart rate from eight-second facial videos captured during normal phone use. Validated on more than 160,000 videos, the system met accuracy targets across skin-tone groups, although usable measurement rates were lower in the darkest skin-tone group and clinical use still requires further testing.
2
Jun 2026
Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer.
2
Jun 2026
When a bacterial infection stops responding to antibiotics, doctors have few options to treat it. Phages-viruses that naturally infect and kill bacteria-have long intrigued clinicians as a potential weapon against these infections.
2
Jun 2026
Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss.
2
Jun 2026
The University of Texas at San Antonio (UT San Antonio) and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of Texas (CPRIT) to further its mission of combating cancers across South Texas.
2
Jun 2026
An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic patients before symptoms occur, according to a study published June 2nd in the open access journal PLOS Medicine by Huangdong Li from the Guangdong Provincial Clinical Research Center for Ocular Diseases in Guangzhou, China, and colleagues.
2
Jun 2026
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset Type 1 diabetes (T1D) in a mouse model of the disease.
2
Jun 2026
A randomized controlled trial conducted at the University of Maryland School of Medicine has found that a five-minute session of proximal intercessory prayer (PIP) - in-person prayer offered by a trained volunteer - significantly reduced pain and anxiety in primary care patients compared to a music control group.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
